Literature DB >> 34087399

Novel antidepressant mechanism of ginsenoside Rg1: Regulating biosynthesis and degradation of connexin43.

Hui-Qin Wang1, Song-Wei Yang2, Yan Gao3, Ying-Jiao Liu2, Xun Li2, Qi-Di Ai2, Mei-Yu Lin2, Yan-Tao Yang2, Qi Zeng2, Yi Zhang4, Zhen-Zhen Wang5, Nai-Hong Chen6.   

Abstract

ETHNOPHARMACOLOGICAL RELEVANCE: Panax ginseng C. A. Meyer is a valuable medicinal herb and "alternative" remedy for the prevention and treatment of depression. Dysfunction of connexin43 (Cx43)-gap junction in astrocytes is predisposed to the precipitation of depression. Ginsenoside Rg1 (Rg1), the main bioactive constituent extracted from ginseng, is efficacious in the management of depression by upregulating the content of Cx43. Our previous results indicated that pretreatment with Rg1 significantly improved Cx43-gap junction in corticosterone (CORT)-treated astrocytes. However, the antidepressant mechanism underlying how Rg1 upregulates Cx43-gap junction in astrocytes hasn't been proposed. AIM OF THE STUDY: To dissect the mechanisms of Rg1 controlling Cx43 levels in primary astrocytes.
METHODS: We examined the changes of the level of Cx43 mRNA, the degradation of Cx43, as well as the ubiquitin-proteasomal and autophagy-lysosomal degradation pathways of Cx43 followed by Rg1 prior to CORT in rat primary astrocytes isolated from prefrontal cortex and hippocampus. Furthermore, the recognized method of scrape loading/dye transfer was performed to detect Cx43-gap junctional function, an essencial indicator of the antidepressant effect.
RESULTS: Pretreatment with Rg1 could reverse CORT-induced downregulation of Cx43 biosynthesis, acceleration of Cx43 degradation, and upregulation of two Cx43 degradation pathways in primary astrocytes.
CONCLUSION: The findings in the present study provide the first evidence highlighting that Rg1 increases Cx43 protein levels through the upregulation of Cx43 mRNA and downregulation of Cx43 degradation, which may be attributed to the effect of Rg1 on the ubiquitin-proteasomal and autophagy-lysosomal degradation pathways of Cx43.
Copyright © 2021 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Antidepressant; Biosynthesis; Connexin 43; Degradation; Degradation pathways; Depression; Ginsenoside Rg1

Mesh:

Substances:

Year:  2021        PMID: 34087399     DOI: 10.1016/j.jep.2021.114212

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  4 in total

1.  Mahonia Alkaloids (MA) Ameliorate Depression Induced Gap Junction Dysfunction by miR-205/Cx43 Axis.

Authors:  Junhui He; Dongmei Li; Jie Wei; Sheng Wang; Shifeng Chu; Zhao Zhang; Fei He; Dongmei Wei; Yi Li; Jiaxiu Xie; Kedao Lai; Naihong Chen; Guining Wei
Journal:  Neurochem Res       Date:  2022-10-12       Impact factor: 4.414

Review 2.  Antidepressant Active Ingredients From Chinese Traditional Herb Panax Notoginseng: A Pharmacological Mechanism Review.

Authors:  Yanwei Li; Qingwan Guo; Junqing Huang; Ziying Wang
Journal:  Front Pharmacol       Date:  2022-06-16       Impact factor: 5.988

Review 3.  Connexin 43: insights into candidate pathological mechanisms of depression and its implications in antidepressant therapy.

Authors:  Ning-Ning Zhang; Yi Zhang; Zhen-Zhen Wang; Nai-Hong Chen
Journal:  Acta Pharmacol Sin       Date:  2022-02-10       Impact factor: 7.169

4.  Effect of WenXin KeLi on Improvement of Arrhythmia after Myocardial Infarction by Intervening PI3K-AKT-mTOR Autophagy Pathway.

Authors:  Meng Lv; Ding Yang; Xiaodi Ji; Lixia Lou; Bo Nie; Jiuli Zhao; Aiming Wu; Mingjing Zhao
Journal:  Evid Based Complement Alternat Med       Date:  2022-09-29       Impact factor: 2.650

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.